Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
SingletO2 Therapeutics Logo
SingletO2 Therapeutics Growth Score
61
CB Rank
183670
Heat Score
50
SingletO2 Therapeutics develops new treatments for periodontal disease using singlet oxygen.
Founded
obfuscation
PrivateGrant New Providence, New Jersey, United States1-10 www.singleto2.com
Biotechnology
Health Care
Therapeutics
Overview

SingletO2 Therapeutics
Total Funding
obfuscation
Growth Score
61
Heat Score
50

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score61
-6 pts
in past quarter
Heat Score 50
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About SingletO2 Therapeutics

CB Rank
183670
SingletO2 Therapeutics develops new treatments for periodontal disease using singlet oxygen.
Founded
obfuscation
PrivateGrant New Providence, New Jersey, United States1-10 www.singleto2.com
Biotechnology
Health Care
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name SingletO2 Therapeutics, LLC
Operating Status Active
Company Type For Profit
Founders  Alan Lyons, Alexander Greer
About the Company
SingletO2 Therapeutics creates new treatments for periodontal disease using singlet oxygen. The company was founded in 2015 and is headquartered in New Providence, New Jersey.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Singlet Oxygen Therapy for Periodontal Disease
A treatment that uses singlet oxygen to kill bacteria and treat advanced periodontal disease without surgery.

Research & Development

SingletO2 Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - SingletO2 Therapeutics Logo
Grant - SingletO2 Therapeutics
1
obfuscation
Commission on Science, Innovation and TechnologyGrant
obfuscation
Grant - SingletO2 Therapeutics Logo
Grant - SingletO2 Therapeutics
1
obfuscation
Commission on Science, Innovation and TechnologyGrant
obfuscation
Grant - SingletO2 Therapeutics Logo
Grant - SingletO2 Therapeutics
1
obfuscation
Commission on Science, Innovation and TechnologyGrant
obfuscation
Grant - SingletO2 Therapeutics Logo
Grant - SingletO2 Therapeutics
1
obfuscation
Commission on Science, Innovation and TechnologyGrant
obfuscation
Grant - SingletO2 Therapeutics Logo
Grant - SingletO2 Therapeutics
1
obfuscation
Commission on Science, Innovation and TechnologyGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - SingletO2 Therapeutics Logo
Grant - SingletO2 Therapeutics
1
obfuscation
Commission on Science, Innovation and TechnologyGrant
obfuscation
Grant - SingletO2 Therapeutics Logo
Grant - SingletO2 Therapeutics
1
obfuscation
Commission on Science, Innovation and TechnologyGrant
obfuscation
Grant - SingletO2 Therapeutics Logo
Grant - SingletO2 Therapeutics
1
obfuscation
Commission on Science, Innovation and TechnologyGrant
obfuscation
Grant - SingletO2 Therapeutics Logo
Grant - SingletO2 Therapeutics
1
obfuscation
Commission on Science, Innovation and TechnologyGrant
obfuscation
Grant - SingletO2 Therapeutics Logo
Grant - SingletO2 Therapeutics
1
obfuscation
Commission on Science, Innovation and TechnologyGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News

News and Press

News•Mar 4, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$120.3KThis year, SingletO2 Therapeutics is projected to spend $120.3K on IT, according to Aberdeen.

Active Website Tech Count

2SingletO2 Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m.

Total IP

1SingletO2 Therapeutics has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is SingletO2 Therapeutics's headquarters? SingletO2 Therapeutics is located in New Providence, New Jersey, United States.Who invested in SingletO2 Therapeutics? SingletO2 Therapeutics has 2 investors including Commission on Science, Innovation and Technology and  Commission on Science, Innovation and Technology.When was the last funding round for SingletO2 Therapeutics? SingletO2 Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are SingletO2 Therapeutics's competitors? Alternatives and possible competitors to SingletO2 Therapeutics may include Blodgett Dental Care, Rifkin Raanan, and  Dr. Michael A. Baylin & Associates.How much funding has SingletO2 Therapeutics raised to date? SingletO2 Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|